Jim Cramer of CNBC has highlighted Vertex Pharmaceuticals as a company to watch in the pharmaceutical space, specifically for its efforts to develop a non-opioid drug for acute pain. Vertex, known for its cystic fibrosis treatment Trikafta, is conducting late-stage trials for its pain drug VX-548. The company aims to create a new class of prescription medications that can effectively relieve pain while addressing the issues associated with opioid use, such as addiction. Cramer believes that if Vertex succeeds in developing an effective non-opioid pain medication, it could represent a significant market opportunity. The late-stage study results for VX-548 are expected within the year.
Leerink Partners, in a note to clients, expressed the view that the investment community may be underestimating the potential of VX-548. The firm, which has a buy-equivalent rating on Vertex shares, drew parallels between the current pain market and the obesity market one to two years ago. The pharmaceutical industry is actively seeking alternatives to opioids for pain management due to concerns about the opioid epidemic and the addictive potential of these drugs.
Cramer’s Charitable Trust, part of the CNBC Investing Club portfolio, holds shares of Eli Lilly (LLY). Lilly is another company exploring new indications for its drug Mounjaro, currently approved to treat type-2 diabetes. Lilly expects Mounjaro’s approved uses to expand to obesity by the end of the year. Cramer has expressed optimism about Mounjaro, suggesting it has the potential to become the best-selling drug of all time.
The focus on non-opioid pain management solutions reflects the broader industry trend of addressing opioid-related challenges and improving patient outcomes. The success of companies like Vertex in developing innovative alternatives could have a significant impact on the pharmaceutical landscape and patient care.
Read more: https://healthcareeverything.com/
Massive MIMO Market report published by Value Market Research, which studies the future outlook of the market.
It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2019-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the Massive MIMO Market include Huawei, Nokia, Ericsson, ZTE, Verizon, Sprint, China Mobile, Airtel, and Deutsche Telekom..
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Massive MIMO Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/massive-mimo-market/download-sampleMarket SegmentationThe broad Massive MIMO Market has been sub-grouped into the Spectrum, Technology, Type of Antennas and Region.
The report studies these subsets with respect to the geographical segmentation.
The strategists can gain a detailed insight and devise appropriate strategies to target specific market.
The Sputtering Targets Market report published by Market.us is an extensive anthology of the essential strand of the Sputtering Targets market, assessed thoroughly by our team of the inquisitor.
The market infiltration report offers perspicacious data and information relevant to the market to familiarize the readers with the lucrative growth anticipation existing in this industry, eventually helping them contrive effective business strategies.
The Sputtering Targets market report has been well organized curated using industry-verified data to offer guidance concerned with the leading manufacturers and suppliers affianced in this sector.
It further focuses on their pricing analysis, gross revenue, product portfolio, sales network & distribution channels, profit margins, and financial estimation.
Regional assessment of Sputtering Targets market unlocks a superfluity of unexploited opportunities in regional and domestic market places.
Detailed company profiling accredits users to evaluate company shares analysis, emerging product lines, the scope of new markets, pricing strategies, innovation probability, and much more.The study throws light on the recent trends, technologies, approaches, and tools, which can boost the performance of companies.
